# Neuralink Launches GB-PRIME Brain-Chip Clinical Trial in Great Britain

> clinical trial · REPORTED · 2025-07-31

On July 31, 2025, Neuralink announced the launch of the GB-PRIME study across two UK sites, with University College London Hospitals NHS Foundation Trust selected as lead site. The multi-site feasibility study evaluates the safety and functionality of Neuralink's N1 implant in patients with severe neurological conditions such as spinal cord injury and ALS, making the UK the first European country to host such a study.

About Neuralink: Neuralink develops fully implantable brain-computer interfaces (BCIs) that allow people with paralysis or neurological conditions to control computers, smartphones, and robotic devices using only their thoughts.

- Company: Neuralink
- Sector: neurotech
- Primary source: https://www.uclh.nhs.uk/news/uclh-evaluate-safety-and-functionality-neuralinks-brain-computer-interface-bci-technology

---
Source: MedFuel Intel news monitor. Verification tier: REPORTED. Informational only, not investment advice. Corrections: media@medfuelinc.com.